The Effects of Tamoxifen on the Endometrium
book-chapter
OA: closed
CC0
Abstract
The second major group of endometrial carcinomasType II carcinomas-generally have a poorer prognosis, appear unrelated to estrogenic stimulation, are of higher grade and stage, and manifest at a later age. The majority of Type II tumors are histologically classified as serous carcinoma, showing striking nuclear atypia and either a glandular or papillary architecture (8). The serous cancers of the endometrium usually appear on an atrophic endometrium, and it has recently been proposed that they arise from a histologically recognizable precursor referred to as endometrial intraepithelial carcinoma (9). This distinguishes them from the endometrioid tumors, which are often seen on hyperplastic endometrium. It is important to note that not all Type II tumors are uterine papillary serous carcinomas. There are other histologic variants including clear cell, mucinous, and other carcinomas that are potentially under-diagnosed because of lack of familiarity with these uncommon subtypes.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (23)
- TAMOXIFEN AND THE UTERUS AND ENDOMETRIUM via openalex
- Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen via openalex
- W1965740586 via openalex
- W1970928234 via openalex
- W1975655572 via openalex
- W1975973972 via openalex
- W1983626262 via openalex
- W1987136076 via openalex
- W2019550358 via openalex
- W2020478108 via openalex
- W2084046556 via openalex
- W2085898246 via openalex
- W2097006862 via openalex
- W2118161058 via openalex
- W2122254445 via openalex
- W2149944230 via openalex
- W2150768356 via openalex
- W2154377786 via openalex
- W2155481621 via openalex
- W2416549068 via openalex
- W1915841877 via openalex
- W2438890976 via openalex
- W1920126165 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK